Prognostic and Clinicopathological Value of Programmed Cell Death Ligand1 Expression in Patients With Small Cell Lung Cancer: A Meta-Analysis

Background: Programmed death-ligand 1 (PD-L1) is an immune checkpoint molecule expressed by cancer cells. Previous studies have demonstrated the prognostic role of PD-L1 expression in patients with small cell lung cancer (SCLC), where the results were inconsistent. Therefore, we conducted a meta-ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Huarong, Zhang, Haimei, Jiang, Yuequan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330709/
https://www.ncbi.nlm.nih.gov/pubmed/32670887
http://dx.doi.org/10.3389/fonc.2020.01079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330709/
https://www.ncbi.nlm.nih.gov/pubmed/32670887
http://dx.doi.org/10.3389/fonc.2020.01079

Ejemplares similares